Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Leukemia | D007938 | — | C95 | 1 | — | — | — | — | 1 |
Myeloid leukemia acute | D015470 | — | C92.0 | 1 | — | — | — | — | 1 |
Myeloid leukemia | D007951 | — | C92 | 1 | — | — | — | — | 1 |
Drug common name | Dinaciclib |
INN | dinaciclib |
Description | 2-[(2S)-1-[3-ethyl-7-[(1-oxido-3-pyridin-1-iumyl)methylamino]-5-pyrazolo[1,5-a]pyrimidinyl]-2-piperidinyl]ethanol is a pyrazolopyrimidine. |
Classification | Small molecule |
Drug class | cyclin dependent kinase inhibitors (formerly-cidib) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12 |
PDB | — |
CAS-ID | 779353-01-4 |
RxCUI | — |
ChEMBL ID | CHEMBL2103840 |
ChEBI ID | — |
PubChem CID | 46926350 |
DrugBank | DB12021 |
UNII ID | 4V8ECV0NBQ (ChemIDplus, GSRS) |